LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 36.00 | 771.67 | 3294 | 3884 | 0.8479 | 0.8634 | MN20160304_L01 | M11 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 36.00 | 771.67 | 3332 | 3884 | 0.8577 | 0.8726 | MN20160304_L01 | N14 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 38.22 | 771.67 | 3550 | 4299 | 0.8257 | 0.8512 | MN20160304_L01 | M11 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 38.22 | 771.67 | 3601 | 4299 | 0.8375 | 0.8619 | MN20160304_L01 | N14 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 40.44 | 771.67 | 3875 | 4738 | 0.8178 | 0.8521 | MN20160304_L01 | M11 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 40.44 | 771.67 | 3977 | 4738 | 0.8393 | 0.8706 | MN20160304_L01 | N14 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 42.67 | 771.67 | 4212 | 5155 | 0.8170 | 0.8578 | MN20160304_L01 | M11 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 42.67 | 771.67 | 4372 | 5155 | 0.8480 | 0.8832 | MN20160304_L01 | N14 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 44.89 | 771.67 | 4585 | 5541 | 0.8274 | 0.8711 | MN20160304_L01 | M11 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 44.89 | 771.67 | 4754 | 5541 | 0.8579 | 0.8951 | MN20160304_L01 | N14 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 47.11 | 771.67 | 4893 | 5941 | 0.8235 | 0.8724 | MN20160304_L01 | M11 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 47.11 | 771.67 | 5186 | 5941 | 0.8728 | 0.9097 | MN20160304_L01 | N14 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 49.33 | 771.67 | 5238 | 6392 | 0.8194 | 0.8736 | MN20160304_L01 | M11 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 49.33 | 771.67 | 5624 | 6392 | 0.8798 | 0.9178 | MN20160304_L01 | N14 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 51.55 | 771.67 | 5594 | 6829 | 0.8191 | 0.8771 | MN20160304_L01 | M11 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 51.55 | 771.67 | 6005 | 6829 | 0.8792 | 0.9198 | MN20160304_L01 | N14 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 53.77 | 771.67 | 5894 | 7256 | 0.8123 | 0.8754 | MN20160304_L01 | M11 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 53.77 | 771.67 | 6378 | 7256 | 0.8790 | 0.9218 | MN20160304_L01 | N14 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 55.99 | 771.67 | 6266 | 7690 | 0.8148 | 0.8803 | MN20160304_L01 | M11 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 55.99 | 771.67 | 6943 | 7690 | 0.9029 | 0.9393 | MN20160304_L01 | N14 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 58.21 | 771.67 | 6536 | 8085 | 0.8084 | 0.8783 | MN20160304_L01 | M11 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 58.21 | 771.67 | 7270 | 8085 | 0.8991 | 0.9382 | MN20160304_L01 | N14 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 60.44 | 771.67 | 6937 | 8530 | 0.8132 | 0.8842 | MN20160304_L01 | M11 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 60.44 | 771.67 | 7667 | 8530 | 0.8988 | 0.9394 | MN20160304_L01 | N14 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 62.66 | 771.67 | 7310 | 8978 | 0.8142 | 0.8872 | MN20160304_L01 | M11 |